4//SEC Filing
Madigan Catherine 4
Accession 0001562180-22-002258
CIK 0001395937other
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 4:24 PM ET
Size
5.8 KB
Accession
0001562180-22-002258
Insider Transaction Report
Form 4
Madigan Catherine
Chief Medical Officer
Transactions
- Award
Stock Options (Right to buy)
2022-03-01$16.06/sh+180,000$2,890,800→ 180,000 totalExercise: $16.06Exp: 2032-03-01→ Common Stock (180,000 underlying)
Footnotes (1)
- [F1]Twenty five percent (25%) of the total number of shares underlying the option shall vest on March 1, 2023, and one-thirty-sixth (1/36th) of the remaining shares underlying the option shall vest monthly thereafter on the last day of each month, subject to the reporting person's continuous service on the relevant vesting dates.
Documents
Issuer
Syndax Pharmaceuticals Inc
CIK 0001395937
Entity typeother
Related Parties
1- filerCIK 0001914577
Filing Metadata
- Form type
- 4
- Filed
- Mar 2, 7:00 PM ET
- Accepted
- Mar 3, 4:24 PM ET
- Size
- 5.8 KB